Pajjiż: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
Trimipramine maleate
Aspen Pharmacare Australia Pty Ltd
Medicine Registered
Surmontil (ANZ) - CMI Page 1 of 4 SURMONTIL ® _Trimipramine (as trimipramine maleate) _ CONSUMER MEDICINE INFORMATION (CMI) This leaflet answers some common questions about Surmontil. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Surmontil against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT SURMONTIL IS USED FOR Surmontil contains the active ingredient trimipramine (as trimipramine maleate). Trimipramine belongs to a group of medicines called tricyclic antidepressants. Surmontil is used to treat major_ _ depression. Medicines for depression are thought to work by their action on brain chemicals called amines which are involved in controlling mood. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY SURMONTIL HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another purpose. This medicine is available only with a doctor’s prescription. There is no evidence that it is addictive. BEFORE YOU TAKE IT _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE SURMONTIL: • IF YOU HAVE HAD AN ALLERGIC REACTION TO IT, TO ANY OTHER ANTIDEPRESSANT MEDICINES OR TO ANY OF THE INGREDIENTS LISTED NEAR THE END OF THIS LEAFLET. Symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty in breathing; swelling of the face, lips, tongue or any other parts of the body; rash, itching or hives Aqra d-dokument sħiħ
SURMONTIL – Product Information Page 1 of 6 PRODUCT INFORMATION SURMONTIL ® TABLETS AND CAPSULES NAME OF THE MEDICINE SURMONTIL tablets and capsules contain trimipramine (as maleate). The chemical name for trimipramine maleate is (2RS)-3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5- yl)-N,N,2-trimethylpropan-1-amine (Z)-butenedioate. (CAS No.: 521-78-8) and the chemical structure is: C 20 H 26 N 2 ,C 4 H 4 O 4 , molecular weight is 410.5. DESCRIPTION Trimipramine maleate is a white or almost white, crystalline powder. It is slightly soluble in water and in ethanol (96%). SURMONTIL tablets contain 25 mg trimipramine. They also contain the excipients calcium hydrogen phosphate, dextrin, indigo carmine, kaolin, magnesium stearate, sodium lauryl sulfate and starch- wheat. SURMONTIL capsules contain 50 mg trimipramine. They also contain the excipients cellulose- microcrystalline, gelatin, indigo carmine, iron oxide yellow, magnesium stearate, opacode S-1-8152 HV Black (PI), silica-colloidal anhydrous, starch-maize and titanium dioxide. PHARMACOLOGY ACTIONSThe anxiolytic action produces restoration of normal sleep patterns and a subjective improvement in the patients. The antidepressant action produces mood elevation, usually within 7 to 10 days. PHARMACOKINETICS Trimipramine is metabolised in the liver to its major metabolite desmethyltrimipramine. Trimipramine is excreted in the urine, mainly in the form of its metabolites, and has been shown to have a mean elimination half life of 24 hours aft Aqra d-dokument sħiħ